The aim of the proposed studies is to analyze the role of the murine Fc receptor complex in B cell differentiation and triggering. Specifically, we will attempt to clone and sequence the gene coding for Lym20.2, a serologically detectable B cell marker that represents an allelic form of the Fc receptor molecule. This gene is either identical or very closely linked to the gene coding for the Mls molecule that has important T cell triggering functions. The precise analysis of the genomic organization and function of this cluster of B cell differentiation antigens will give insights into the molecular mechanism of T cell-B cell interaction. Furthermore, it will provide gene probes that allow the characterization of human B cell malignancies, which represents the long term significance of this project. We will construct genomic transfection libraries in heterologous species of fibroblasts, using chromosomal DNA from Lym20.2+ tissue, and select for stable transfectants that express Lym20. We will then prepare specific subtractive cDNA probes, in order to screen cDNA and genomic cosmid libraries for the Lym20 gene. In parallel, we will use synthetic oligonucleotide probes whose sequence is deduced from a partial amino acid sequence of the Lym20.2 molecule. Having established the identity of the selected cDNA and cosmid clones in chromosomal mapping and transfection experiments, we will analyze the relationship between the Lym20/Fc receptor molecule and the Mls gene product. Finally, we will analyze the mechanism by which Mls alleles control induction of T cell proliferation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI014910-10
Application #
3125924
Study Section
Immunobiology Study Section (IMB)
Project Start
1978-04-01
Project End
1989-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
10
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Kulik, Liudmila; Chen, Kuan; Huber, Brigitte T et al. (2011) Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists. Mol Immunol 48:883-94
Hsiao, Francis C; Tai, Albert K; Deglon, Agnes et al. (2009) EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology 385:261-6
Chen, Gang; Tai, Albert K; Lin, Miao et al. (2007) Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death. Eur J Immunol 37:663-74
Tai, Albert K; Lin, Miao; Chang, Francesca et al. (2006) Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen. J Immunol 177:3178-84
Hsiao, Francis C; Lin, Miao; Tai, Albert et al. (2006) Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J Immunol 177:2056-60
Sicat, Jocelyn; Sutkowski, Natalie; Huber, Brigitte T (2005) Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J Rheumatol 32:1821-31
Chen, Gang; Tai, Albert K; Lin, Miao et al. (2005) Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J Immunol 175:2212-8
Sutkowski, N; Conrad, B; Thorley-Lawson, D A et al. (2001) Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15:579-89
Yasui, D H; Genetta, T; Kadesch, T et al. (1998) Transcriptional repression of the IL-2 gene in Th cells by ZEB. J Immunol 160:4433-40
Gross, D M; Steere, A C; Huber, B T (1998) T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 160:1022-8

Showing the most recent 10 out of 40 publications